CNR Institutional Research Information System

RICCIO, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.446
NA - Nord America 919
EU - Europa 287
SA - Sud America 273
AF - Africa 34
OC - Oceania 2
Totale 2.961
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 887
SG - Singapore 641
CN - Cina 319
BR - Brasile 224
VN - Vietnam 154
HK - Hong Kong 141
FR - Francia 109
IT - Italia 76
KR - Corea 61
IN - India 31
GB - Regno Unito 20
JP - Giappone 20
BD - Bangladesh 15
CA - Canada 15
FI - Finlandia 15
AR - Argentina 14
NL - Olanda 14
DE - Germania 11
EC - Ecuador 8
IL - Israele 8
IQ - Iraq 8
MA - Marocco 8
MX - Messico 8
UZ - Uzbekistan 7
ZA - Sudafrica 7
AT - Austria 6
CO - Colombia 6
PE - Perù 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 5
PH - Filippine 5
TR - Turchia 5
UA - Ucraina 5
EG - Egitto 4
VE - Venezuela 4
BO - Bolivia 3
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
RO - Romania 3
SA - Arabia Saudita 3
SE - Svezia 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
AU - Australia 2
BE - Belgio 2
CL - Cile 2
ES - Italia 2
GM - Gambi 2
GR - Grecia 2
GT - Guatemala 2
IE - Irlanda 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
MD - Moldavia 2
PT - Portogallo 2
PY - Paraguay 2
RU - Federazione Russa 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
EE - Estonia 1
ET - Etiopia 1
GF - Guiana Francese 1
HU - Ungheria 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
PL - Polonia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 2.961
Salva come PNG Salva come JPEG
Città #
Santa Clara 436
Singapore 378
Hefei 144
Hong Kong 141
Lauterbourg 74
San Jose 70
Seoul 60
Ashburn 46
Beijing 45
Hanoi 45
Ho Chi Minh City 41
Los Angeles 30
Buffalo 19
New York 14
Dallas 11
São Paulo 11
Tokyo 11
Rio de Janeiro 10
Helsinki 9
Secaucus 9
Newark 8
Rome 8
Washington 8
Clifton 7
Minamishinagawa 7
Redondo Beach 7
Belo Horizonte 6
Haiphong 6
Hyderabad 6
Naples 6
Shanghai 6
Tashkent 6
Brasília 5
Curitiba 5
Elk Grove Village 5
Frankfurt am Main 5
Lấp Vò 5
Milan 5
North Bergen 5
Quận Một 5
Biên Hòa 4
Guarulhos 4
Marseille 4
Mogi das Cruzes 4
Montreal 4
Mumbai 4
New Delhi 4
Ninh Bình 4
Porto Alegre 4
Quito 4
Toronto 4
Vũng Tàu 4
Amman 3
Amsterdam 3
Baghdad 3
Bengaluru 3
Bắc Giang 3
Campinas 3
Canoas 3
Casablanca 3
Caserta 3
Changsha 3
City of London 3
Columbus 3
Council Bluffs 3
Da Nang 3
Dhaka 3
Florence 3
Guangzhou 3
Hải Dương 3
Lappeenranta 3
Lima 3
London 3
Montevideo 3
Monzambano 3
Nairobi 3
Orem 3
Paris 3
Piscataway 3
Quận Bình Thạnh 3
Salvador 3
Stockholm 3
Turku 3
Vienna 3
Vitória da Conquista 3
Xi'an 3
Atlanta 2
Banjul 2
Betim 2
Birmingham 2
Blumenau 2
Bogotá 2
Brisbane 2
Brooklyn 2
Buenos Aires 2
Bình An 2
Cairo 2
Calgary 2
Campo Erê 2
Campo Grande 2
Totale 1.903
Salva come PNG Salva come JPEG
Nome #
The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease 87
Molecular and clinical studies in five index cases with novel mutations in the GLA gene. 81
Early Cardiac involvement affects left ventricular longitudinal function in females carrying ?- galactosidase a mutation role of hybrid positron emission tomography and magnetic resonance imaging and speckle-tracking echocardiography 74
Tolvaptan in ADPKD: a turning point or an unsustainable therapy? One year of "real life" experience 70
Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis 66
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group 63
Glomerular Hyperfiltration: An Early Marker of Nephropathy in Fabry Disease 63
ADPKD and metformin: from bench to bedside 62
Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease Case Reports 60
Immunomodulatory effect of continuous venovenous hemofiltration during sepsis: Preliminary data 54
Microstructural damage of the cortico-striatal and thalamo-cortical fibers in Fabry disease: a diffusion MRI tractometry study 54
Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data 53
Methylome profiling in Fabry disease in clinical practice: a proof of concept 53
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease 53
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 53
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: A cost-minimization analysis 52
Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease 48
Left ventricular radial strain impairment precedes hypertrophy in Anderson-Fabry disease 42
Therapeutic advances in ADPKD: the future awaits 40
Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review 40
Acute Kidney Injury in COVID-19 Pandemic 40
Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocol 40
DNA methylation impact on Fabry disease 40
Impact of COVID-19 pandemic on CKD outpatient management 39
COVID-19 Experience in Hemodialysis Patients: A Cue for Therapeutic Heparin-Based Strategies 38
Does left ventricular function predict cardiac outcome in Anderson-Fabry disease? 38
Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: A case report 37
The Retinal Vessel Density as a New Vascular Biomarker in Multisystem Involvement in Fabry Disease: An Optical Coherence Tomography Angiography Study 37
Evidence that p-cresol and IL-6 are adsorbed by the HFR cartridge: Towards a new strategy to decrease systemic inflammation in dialyzed patients? 36
Parapelvic cysts, a distinguishing feature of renal Fabry disease. 36
Striatonigral involvement in Fabry Disease: A quantitative and volumetric Magnetic Resonance Imaging study 36
Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: A randomized trial 35
Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995-2019 35
Role of serial cardiac 18F-FDG PET-MRI in Anderson-Fabry disease: a pilot study 34
Human mature adipocytes express albumin and this expression is not regulated by inflammation 34
Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience 34
Metformin in autosomal dominant polycystic kidney disease: Experimental hypothesis or clinical fact? 33
Layer-specific longitudinal strain in Anderson-Fabry disease at diagnosis: A speckle tracking echocardiography analysis 32
Atrial septum aneurysm: an unusual manifestation in ADPKD? 32
Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: A randomized trial 32
The potential use of biomarkers in predicting contrast-induced acute kidney injury 31
Renal Denervation for Resistant Hypertension: Time to Improve Patient Selection. The Lesson From ADPKD 30
Nutritional treatment in chronic kidney disease: the concept of nephroprotection 29
Effects of a Diet Rich in N-3 Polyunsaturated Fatty Acids on Systemic Inflammation in Renal Transplant Recipients 29
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 28
Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with anderson-fabry disease 28
Data on the assessment of LV mechanics by speckle tracking echocardiography in ADPKD patients 28
Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin? 27
Redefining the pulvinar sign in fabry disease 27
Current tissue molecular markers in colorectal cancer: A literature review 27
Endothelial-mediated coronary flow reserve in patients with Anderson-Fabry disease 27
Nutritional management in renal transplant recipients: A transplant team opportunity to improve graft survival 27
Renal denervation in ADPKD: an exceptional case 27
Arterial aneurysms: Autosomal dominant polycystic kidney disease, Marfan syndrome or both? 26
Loculated fluid collections evidenced by peritoneal scintigraphy 26
Pituitary function and morphology in Fabry disease 26
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 25
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial 25
Agalsidase alfa and agalsidase beta in the treatment of fabry disease: Does the dose really matter? 25
6-tips diet: a simplified dietary approach in patients with chronic renal disease. A clinical randomized trial 24
Plasma p-Cresol Lowering Effect of Sevelamer in Peritoneal Dialysis Patients: Evidence from a Cross-Sectional Observational Study 24
Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media 23
Complications of native arteriovenous fistula: The role of color doppler ultrasonography 23
Polycystic horseshoe kidney 23
Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy 23
Focal reduction in left ventricular 123 I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson-Fabry disease 23
Optical Coherence Tomography Angiography Findings in Fabry Disease 23
Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trial 23
Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial 23
Catheter-based renal denervation in ADPKD: Just for pain control? 22
Antiproteinuric effect of add-on paricalcitol in Fabry disease patients: a prospective observational study. 22
Early Biomarkers of Fabry Nephropathy: A Review of the Literature 22
Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study 22
Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients 22
Multiple sclerosis and fabry Disease, two sides of the coin? The case of an Italian family 22
Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease 21
The switch of enzyme therapy in Fabry disease 21
Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury 21
Effects of switching from agalsidase beta to agalsidase alfa in 10 patients with anderson-fabry disease 21
Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer 21
A strange epigastric pain 20
Pleural effusion in peritoneal dialysis: Overload or leakage? 19
Switch to agalsidase alfa after shortage of agalsidase beta in Fabry disease: A systematic review and meta-Analysis of the literature 18
Fanconi syndrome with lysinuric protein intolerance 18
Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin 18
The kidney in Fabry's disease 18
Totale 2.984
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.501
article - articoli 11.501
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.002
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20242 0 0 0 0 0 0 0 0 0 0 1 1
2024/20251.264 15 9 84 39 446 17 26 39 36 40 277 236
2025/20261.718 90 124 159 280 328 32 276 149 92 106 82 0
Totale 2.984